Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.270
-0.050 (-3.79%)
Jan 17, 2025, 4:00 PM EST - Market closed

Citius Oncology Statistics

Total Valuation

CTOR has a market cap or net worth of $90.87 million. The enterprise value is $94.67 million.

Market Cap 90.87M
Enterprise Value 94.67M

Important Dates

The next estimated earnings date is Friday, February 21, 2025, before market open.

Earnings Date Feb 21, 2025
Ex-Dividend Date n/a

Share Statistics

CTOR has 71.55 million shares outstanding. The number of shares has increased by 0.82% in one year.

Current Share Class 71.55M
Shares Outstanding 71.55M
Shares Change (YoY) +0.82%
Shares Change (QoQ) +3.28%
Owned by Insiders (%) n/a
Owned by Institutions (%) 0.05%
Float 5.50M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.97
P/TBV Ratio 1.97
P/FCF Ratio 719.19
P/OCF Ratio 719.19
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 749.26

Financial Position

The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.08.

Current Ratio 0.34
Quick Ratio n/a
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF 30.08
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -59.01% and return on invested capital (ROIC) is -34.07%.

Return on Equity (ROE) -59.01%
Return on Assets (ROA) -19.47%
Return on Capital (ROIC) -34.07%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, CTOR has paid $576,000 in taxes.

Income Tax 576,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.38% in the last 52 weeks. The beta is -0.64, so CTOR's price volatility has been lower than the market average.

Beta (5Y) -0.64
52-Week Price Change -88.38%
50-Day Moving Average 1.14
200-Day Moving Average 6.71
Relative Strength Index (RSI) 54.07
Average Volume (20 Days) 170,975

Short Selling Information

The latest short interest is 84,449, so 0.12% of the outstanding shares have been sold short.

Short Interest 84,449
Short Previous Month 77,332
Short % of Shares Out 0.12%
Short % of Float 1.53%
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -20.57M
Pretax Income n/a
Net Income -21.15M
EBITDA n/a
EBIT -20.57M
Earnings Per Share (EPS) -$0.31
Full Income Statement

Balance Sheet

The company has $112 in cash and $3.80 million in debt, giving a net cash position of -$3.80 million or -$0.05 per share.

Cash & Cash Equivalents 112
Total Debt 3.80M
Net Cash -3.80M
Net Cash Per Share -$0.05
Equity (Book Value) 46.14M
Book Value Per Share 0.64
Working Capital -21.73M
Full Balance Sheet

Cash Flow

Operating Cash Flow 126,353
Capital Expenditures n/a
Free Cash Flow 126,353
FCF Per Share $0.00
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CTOR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.82%
Shareholder Yield -0.82%
Earnings Yield -23.27%
FCF Yield 0.14%

Analyst Forecast

The average price target for CTOR is $4.50, which is 254.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.50
Price Target Difference 254.33%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2